Author:
Hatori Nobuo,Segawa Daisuke,Shimizu Masafumi,Bito Hiroyasu,Fukuda Isao,Yoshizu Hiroshi,Tanaka Susumu
Subject
Cardiology and Cardiovascular Medicine
Reference29 articles.
1. Farber NE, Gross GJ (1989) Prostaglandin E1 attenuates postischemic contractile dysfunction after brief coronary occlusion and reperfusion. Am Heart J 118:17–24.
2. Priebe HJ (1988) Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension. Am J Physiol 255:H1232-H1239.
3. Monacada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665.
4. Sinzinger H, O'Grady J, Fitscha P, Rauscha F, Kaliman J (1988) Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human sites after intravenous and intraarterial application. Thromb Res 50:749–755.
5. Kitsis EA, Weissmann G, Abramson SB (1991) The prostaglandin paradox: Additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol. J Rheumatol 18:1461–1465.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献